Approval Year
| Substance Class |
Structurally Diverse
Created
by
admin
on
Edited
Fri Dec 15 18:01:54 GMT 2023
by
admin
on
Fri Dec 15 18:01:54 GMT 2023
|
| Source Materials Class | ORGANISM |
| Source Materials Type | HUMAN |
| Source Materials State | ISOLATED |
| Source Materials Parent | |
| Part | BLOOD |
| Fraction Material Type | PROTEIN |
| Fraction Name | IMMUNOGLOBULIN |
| Record UNII |
XII270YC6M
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Related Record | Type |
|---|
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NDF-RT |
N0000184164
Created by
admin on Fri Dec 15 18:01:54 GMT 2023 , Edited by admin on Fri Dec 15 18:01:54 GMT 2023
|
||
|
FDA ORPHAN DRUG |
228506
Created by
admin on Fri Dec 15 18:01:54 GMT 2023 , Edited by admin on Fri Dec 15 18:01:54 GMT 2023
|
||
|
NCI_THESAURUS |
C2701
Created by
admin on Fri Dec 15 18:01:54 GMT 2023 , Edited by admin on Fri Dec 15 18:01:54 GMT 2023
|
||
|
NDF-RT |
N0000184164
Created by
admin on Fri Dec 15 18:01:54 GMT 2023 , Edited by admin on Fri Dec 15 18:01:54 GMT 2023
|
||
|
WHO-ATC |
J06BB04
Created by
admin on Fri Dec 15 18:01:54 GMT 2023 , Edited by admin on Fri Dec 15 18:01:54 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
XII270YC6M
Created by
admin on Fri Dec 15 18:01:54 GMT 2023 , Edited by admin on Fri Dec 15 18:01:54 GMT 2023
|
PRIMARY | |||
|
26744
Created by
admin on Fri Dec 15 18:01:54 GMT 2023 , Edited by admin on Fri Dec 15 18:01:54 GMT 2023
|
PRIMARY | RxNorm | ||
|
N0000183365
Created by
admin on Fri Dec 15 18:01:54 GMT 2023 , Edited by admin on Fri Dec 15 18:01:54 GMT 2023
|
PRIMARY | Passively Acquired Immunity [PE] | ||
|
C80827
Created by
admin on Fri Dec 15 18:01:54 GMT 2023 , Edited by admin on Fri Dec 15 18:01:54 GMT 2023
|
PRIMARY | |||
|
XII270YC6M
Created by
admin on Fri Dec 15 18:01:54 GMT 2023 , Edited by admin on Fri Dec 15 18:01:54 GMT 2023
|
PRIMARY | |||
|
N0000184152
Created by
admin on Fri Dec 15 18:01:54 GMT 2023 , Edited by admin on Fri Dec 15 18:01:54 GMT 2023
|
PRIMARY | Virus-specific Hyperimmune Globulins [Chemical/Ingredient] | ||
|
N0000184009
Created by
admin on Fri Dec 15 18:01:54 GMT 2023 , Edited by admin on Fri Dec 15 18:01:54 GMT 2023
|
PRIMARY | Virus Neutralization [MoA] | ||
|
N0000007920
Created by
admin on Fri Dec 15 18:01:54 GMT 2023 , Edited by admin on Fri Dec 15 18:01:54 GMT 2023
|
PRIMARY | Immunoglobulins [Chemical/Ingredient] |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SUB_CONCEPT->SUBSTANCE |
|
||
|
|
SUB_CONCEPT->SUBSTANCE | |||
|
|
TARGET ORGANISM->INHIBITOR |
|
||
|
|
SUB_CONCEPT->SUBSTANCE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY | |||
|
|
ACTIVE MOIETY |
|
Agent Modifications
| Modification Process | Modification Role | Modification Type | Amount | Fragment Name | Fragment ID |
|---|---|---|---|---|---|
| DONOR SELECTED | TARGETED ANTIGEN | IMMUNOLOGICAL |
|
HEPATITIS B VIRUS | 77H9EM77P7 |